Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy

Jeonggeun Moon, Young Guk Ko, Namsik Chung, Jong Won Ha, seokmin kang, Eui Young Choi, Se Joong Rim

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: Some patients with nonischemic left ventricular (LV) systolic failure recover to have normal LV systolic function. However, few studies on the rates of recovery and recurrence have been reported, and no definitive indicators that can predict the recurrence of LV dysfunction in recovered idiopathic dilated cardiomyopathy (IDCMP) patients have been determined. It was hypothesized that patients who recovered from nonischemic LV dysfunction have a substantial risk for recurrent heart failure. Methods: Forty-two patients (32 men) with IDCMP (mean [± SD] age 56.9±8.7 years) who recovered from systolic heart failure (LV ejection fraction [LVEF] of 26.5±6.9% at initial presentation) to a near-normal state (LVEF of 40% or greater, and a 10% increase or greater in absolute value) were monitored for recurrence of LV systolic dysfunction. Patients with significant coronary artery disease were excluded. Patients were monitored for 41.0±26.3 months after recovery (LVEF 53.4±7.6%) from LV dysfunction. Results: LV systolic dysfunction reappeared (LVEF 27.5±8.1%) during the follow-up period in eight of 42 patients (19.0%). No significant difference between the groups with or without recurrent heart failure was observed in the baseline clinical and echocardiographic characteristics. However, more patients in the recurred IDCMP group than those in the group that maintained the recovery state had discontinued antiheart failure medication (62.5% versus 5.9%, P<0.05). Conclusions: LV dysfunction recurs in some patients with reversible IDCMP. The recurrence was significantly correlated with the discontinuation of antiheart failure drugs. The results suggest that continuous medical therapy may be mandatory in patients who recover from LV systolic dysfunction.

Original languageEnglish
JournalCanadian Journal of Cardiology
Volume25
Issue number5
DOIs
Publication statusPublished - 2009 Jan 1

Fingerprint

Dilated Cardiomyopathy
Left Ventricular Dysfunction
Recurrence
Heart Failure
Systolic Heart Failure
Left Ventricular Function
Stroke Volume
Coronary Artery Disease

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Moon, Jeonggeun ; Ko, Young Guk ; Chung, Namsik ; Ha, Jong Won ; kang, seokmin ; Choi, Eui Young ; Rim, Se Joong. / Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy. In: Canadian Journal of Cardiology. 2009 ; Vol. 25, No. 5.
@article{876b1b8daf6746859f008a61c2803780,
title = "Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy",
abstract = "Background: Some patients with nonischemic left ventricular (LV) systolic failure recover to have normal LV systolic function. However, few studies on the rates of recovery and recurrence have been reported, and no definitive indicators that can predict the recurrence of LV dysfunction in recovered idiopathic dilated cardiomyopathy (IDCMP) patients have been determined. It was hypothesized that patients who recovered from nonischemic LV dysfunction have a substantial risk for recurrent heart failure. Methods: Forty-two patients (32 men) with IDCMP (mean [± SD] age 56.9±8.7 years) who recovered from systolic heart failure (LV ejection fraction [LVEF] of 26.5±6.9{\%} at initial presentation) to a near-normal state (LVEF of 40{\%} or greater, and a 10{\%} increase or greater in absolute value) were monitored for recurrence of LV systolic dysfunction. Patients with significant coronary artery disease were excluded. Patients were monitored for 41.0±26.3 months after recovery (LVEF 53.4±7.6{\%}) from LV dysfunction. Results: LV systolic dysfunction reappeared (LVEF 27.5±8.1{\%}) during the follow-up period in eight of 42 patients (19.0{\%}). No significant difference between the groups with or without recurrent heart failure was observed in the baseline clinical and echocardiographic characteristics. However, more patients in the recurred IDCMP group than those in the group that maintained the recovery state had discontinued antiheart failure medication (62.5{\%} versus 5.9{\%}, P<0.05). Conclusions: LV dysfunction recurs in some patients with reversible IDCMP. The recurrence was significantly correlated with the discontinuation of antiheart failure drugs. The results suggest that continuous medical therapy may be mandatory in patients who recover from LV systolic dysfunction.",
author = "Jeonggeun Moon and Ko, {Young Guk} and Namsik Chung and Ha, {Jong Won} and seokmin kang and Choi, {Eui Young} and Rim, {Se Joong}",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/S0828-282X(09)70497-0",
language = "English",
volume = "25",
journal = "Canadian Journal of Cardiology",
issn = "0828-282X",
publisher = "Pulsus Group Inc.",
number = "5",

}

Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy. / Moon, Jeonggeun; Ko, Young Guk; Chung, Namsik; Ha, Jong Won; kang, seokmin; Choi, Eui Young; Rim, Se Joong.

In: Canadian Journal of Cardiology, Vol. 25, No. 5, 01.01.2009.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy

AU - Moon, Jeonggeun

AU - Ko, Young Guk

AU - Chung, Namsik

AU - Ha, Jong Won

AU - kang, seokmin

AU - Choi, Eui Young

AU - Rim, Se Joong

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Background: Some patients with nonischemic left ventricular (LV) systolic failure recover to have normal LV systolic function. However, few studies on the rates of recovery and recurrence have been reported, and no definitive indicators that can predict the recurrence of LV dysfunction in recovered idiopathic dilated cardiomyopathy (IDCMP) patients have been determined. It was hypothesized that patients who recovered from nonischemic LV dysfunction have a substantial risk for recurrent heart failure. Methods: Forty-two patients (32 men) with IDCMP (mean [± SD] age 56.9±8.7 years) who recovered from systolic heart failure (LV ejection fraction [LVEF] of 26.5±6.9% at initial presentation) to a near-normal state (LVEF of 40% or greater, and a 10% increase or greater in absolute value) were monitored for recurrence of LV systolic dysfunction. Patients with significant coronary artery disease were excluded. Patients were monitored for 41.0±26.3 months after recovery (LVEF 53.4±7.6%) from LV dysfunction. Results: LV systolic dysfunction reappeared (LVEF 27.5±8.1%) during the follow-up period in eight of 42 patients (19.0%). No significant difference between the groups with or without recurrent heart failure was observed in the baseline clinical and echocardiographic characteristics. However, more patients in the recurred IDCMP group than those in the group that maintained the recovery state had discontinued antiheart failure medication (62.5% versus 5.9%, P<0.05). Conclusions: LV dysfunction recurs in some patients with reversible IDCMP. The recurrence was significantly correlated with the discontinuation of antiheart failure drugs. The results suggest that continuous medical therapy may be mandatory in patients who recover from LV systolic dysfunction.

AB - Background: Some patients with nonischemic left ventricular (LV) systolic failure recover to have normal LV systolic function. However, few studies on the rates of recovery and recurrence have been reported, and no definitive indicators that can predict the recurrence of LV dysfunction in recovered idiopathic dilated cardiomyopathy (IDCMP) patients have been determined. It was hypothesized that patients who recovered from nonischemic LV dysfunction have a substantial risk for recurrent heart failure. Methods: Forty-two patients (32 men) with IDCMP (mean [± SD] age 56.9±8.7 years) who recovered from systolic heart failure (LV ejection fraction [LVEF] of 26.5±6.9% at initial presentation) to a near-normal state (LVEF of 40% or greater, and a 10% increase or greater in absolute value) were monitored for recurrence of LV systolic dysfunction. Patients with significant coronary artery disease were excluded. Patients were monitored for 41.0±26.3 months after recovery (LVEF 53.4±7.6%) from LV dysfunction. Results: LV systolic dysfunction reappeared (LVEF 27.5±8.1%) during the follow-up period in eight of 42 patients (19.0%). No significant difference between the groups with or without recurrent heart failure was observed in the baseline clinical and echocardiographic characteristics. However, more patients in the recurred IDCMP group than those in the group that maintained the recovery state had discontinued antiheart failure medication (62.5% versus 5.9%, P<0.05). Conclusions: LV dysfunction recurs in some patients with reversible IDCMP. The recurrence was significantly correlated with the discontinuation of antiheart failure drugs. The results suggest that continuous medical therapy may be mandatory in patients who recover from LV systolic dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=65949101861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65949101861&partnerID=8YFLogxK

U2 - 10.1016/S0828-282X(09)70497-0

DO - 10.1016/S0828-282X(09)70497-0

M3 - Article

VL - 25

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

SN - 0828-282X

IS - 5

ER -